109 related articles for article (PubMed ID: 20626738)
1. Thrombolysis with alteplase: a non-invasive treatment for occluded arteriovenous fistulas and grafts.
Tseke P; Kalyveza E; Politis E; Giapraka N; Andriopoulos C; Balitsari A; Papatzikos L; Stavgianoudakis G
Artif Organs; 2011 Jan; 35(1):58-62. PubMed ID: 20626738
[TBL] [Abstract][Full Text] [Related]
2. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
[TBL] [Abstract][Full Text] [Related]
3. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
[TBL] [Abstract][Full Text] [Related]
4. Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access.
Tan RY; Pang SC; Teh SP; Lee KG; Chong TT; Gogna A; Tan CS
J Vasc Access; 2019 Sep; 20(5):501-506. PubMed ID: 30585114
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomechanical thrombectomy with the Castañeda brush catheter in thrombosed hemodialysis grafts and native fistulas.
Heye S; Van Kerkhove F; Claes K; Maleux G
J Vasc Interv Radiol; 2007 Nov; 18(11):1383-8. PubMed ID: 18003988
[TBL] [Abstract][Full Text] [Related]
6. Benefits of Long Versus Short Thrombolysis Times for Acutely Thrombosed Hemodialysis Native Fistulas.
Regus S; Lang W; Heinz M; Uder M; Schmid A
Vasc Endovascular Surg; 2017 Jul; 51(5):233-239. PubMed ID: 28639916
[TBL] [Abstract][Full Text] [Related]
7. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study examining thrombolysis for occluded femoro-popliteal grafts - is it worthwhile?
Abraham-Igwe CU; Siddiqui MR; Geddes LT; Halls J; Irvine A; Browning N
Int J Surg; 2011; 9(8):632-5. PubMed ID: 21875696
[TBL] [Abstract][Full Text] [Related]
9. Tenecteplase in the treatment of thrombosed hemodialysis grafts.
Falk A; Harbour K
Cardiovasc Intervent Radiol; 2005; 28(4):472-5. PubMed ID: 16001142
[TBL] [Abstract][Full Text] [Related]
10. Salvage of occluded autologous arteriovenous fistulae.
Schon D; Mishler R
Am J Kidney Dis; 2000 Oct; 36(4):804-10. PubMed ID: 11007684
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator (t-PA) efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
CANNT J; 1999; 9(4):25-8. PubMed ID: 15714785
[TBL] [Abstract][Full Text] [Related]
12. Recombinant peptides in thrombolysis.
Campbell J; Hilleman D
Semin Thromb Hemost; 2010 Jul; 36(5):529-36. PubMed ID: 20632250
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator.
Curl GR; Jakubowski JA; Deykin D; Bush HL
Circulation; 1986 Sep; 74(3 Pt 2):I21-4. PubMed ID: 3091289
[TBL] [Abstract][Full Text] [Related]
14. The management and outcome of occluded haemodialysis access: a retrospective audit.
Yehia M; McDonald M; Walker R
N Z Med J; 2002 Nov; 115(1166):U258. PubMed ID: 12552276
[TBL] [Abstract][Full Text] [Related]
15. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
Shea M; Hmiel SP; Beck AM
Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
[TBL] [Abstract][Full Text] [Related]
16. In-center thrombolysis for clotted AV access: a cohort review.
Umanath K; Morrison RS; Christopher Wilbeck J; Schulman G; Bream P; Dwyer JP
Semin Dial; 2013; 26(1):124-9. PubMed ID: 22784240
[TBL] [Abstract][Full Text] [Related]
17. Mechanical thrombectomy of occluded hemodialysis native fistulas and grafts using a hydrodynamic thrombectomy catheter: preliminary experience.
Sahni V; Kaniyur S; Malhotra A; Fan S; Blakeney C; Fotheringham T; Sobeh M; Matson M
Cardiovasc Intervent Radiol; 2005; 28(6):714-21. PubMed ID: 16059764
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term results after intra-arterial thrombolysis of occluded lower extremity bypass grafts using recombinant tissue plasminogen activator for acute limb-threatening ischemia.
Khosla S; Jain P; Manda R; Razminia M; Guerrero M; Trivedi A; Vidyarthi V; Elbazour M; Kunjummen B; Ahmed A; Lubell D
Am J Ther; 2003; 10(1):3-6. PubMed ID: 12522513
[TBL] [Abstract][Full Text] [Related]
19. [Local intra-arterial thrombolysis. Results in arterial thromboses and graft occlusions].
Hansen AK; Egeblad MR; Klaerke A
Ugeskr Laeger; 1997 Mar; 159(13):1950-3. PubMed ID: 9123634
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue plasminogen activator to declot dialysis fistulas.
Boobes Y; al Hassan H; Neglen P; Obeid K; Denour N
J Nephrol; 1997; 10(2):107-10. PubMed ID: 9238617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
